Chemoinformaics analysis of BENZYLADENINE-7-O-BETA-D-GLUCOSIDE
| Molecular Weight | 387.396 | nRot | 5 |
| Heavy Atom Molecular Weight | 366.228 | nRig | 23 |
| Exact Molecular Weight | 387.154 | nRing | 4 |
| Solubility: LogS | -2.188 | nHRing | 3 |
| Solubility: LogP | -0.375 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
| nHA | 10 | APOL | 53.5727 |
| nHD | 5 | BPOL | 28.5033 |
| QED | 0.379 |
| Synth | 4.262 |
| Natural Product Likeliness | 0.76 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.754 |
| HIA | 0.987 |
| CACO-2 | -5.67 |
| MDCK | 0.00000586 |
| BBB | 0.774 |
| PPB | 0.27749 |
| VDSS | 2.776 |
| FU | 0.658991 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.186 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.161 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.054 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.073 |
| CL | 7.808 |
| T12 | 0.687 |
| hERG | 0.053 |
| Ames | 0.084 |
| ROA | 0.388 |
| SkinSen | 0.062 |
| Carcinogencity | 0.043 |
| EI | 0.007 |
| Respiratory | 0.924 |
| NR-Aromatase | 0.937 |
| Antiviral | Yes |
| Prediction | 0.895026 |